Telavant produces drugs for people suffering from inflammatory and fibrotic diseases and is in the process of developing a 'promising new therapy' for patients with Crohn's disease.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
